Scientific, technical, and administrative support for infectious disease research and surveillance to identify and characterize medical threats to the warfighter in area of responsibility (AOR).
Active Awarded Last action
- Contract number
- HT942525F0114
- Awardee
-
Culmen International, LLC UEI P8T9JZVLSXA3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,575,890
Award facts
- Contract value 30% obligated
-
- $5,165,532.85 Current, with exercised options
- $15,355,208.13 Potential, with all options
- Completion date 32% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Georgia
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $733,051 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,374,197 | |
| Funding Only Action | -$188,043 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Change Order | $457,993 | |
| Exercise an Option | $230,345 | |
| Original award | $1,968,347 |
About this award
The Defense Health Agency issued a delivery order to Culmen International, LLC on March 13, 2025, with a ceiling value of $15.3 million under the Omnibus IV Military Medical Research and Development IDIQ for scientific, technical, and administrative support for infectious disease research and surveillance to identify and characterize medical threats to the warfighter in area of responsibility.
Omnibus IV is a multiple-award IDIQ supporting military medical research and development across the Defense Health Agency and related DoD components. Place of performance is Georgia. The order runs through March 12, 2030. Work encompasses infectious disease surveillance and characterization of medical threats to warfighter populations, delivered on a cost-plus-fixed-fee basis with no set-aside designation.
Quick answers
Who was awarded contract HT942525F0114?
HT942525F0114 was awarded to Culmen International, LLC by Defense Health Agency (Department of Defense) on March 13, 2025.
How much is contract HT942525F0114 worth?
The government has obligated $4,575,890 on HT942525F0114. Its current value, with exercised options, is $5,165,533. Its potential value, with all options, is $15,355,208.
Is contract HT942525F0114 an order under another contract?
Yes. HT942525F0114 is a delivery order under HT001122D0053, an indefinite delivery contract, on Omnibus IV Military Medical Research And Development (OMNIBUS IV).
Was contract HT942525F0114 competed?
The extent of competition for HT942525F0114 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award